Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents. 1981

A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley

The susceptibilities of 11 strains representing the five recognized species of Legionella were determined by agar dilution testing on buffered charcoal-yeast extract agar. All of the legionellae tested were susceptible to rifampin, erythromycin, rosaramycin, chloramphenicol, and the aminoglycosides and were resistant to clindamycin and vancomycin. Susceptibilities to penicillins and cephalosporins were variable. Legionella micdadei, Legionella bozemanii, and Legionella gormanii were susceptible to these agents, but minimal inhibitory concentrations for each species were different. Legionella dumoffii resembled Legionella pneumophila in being resistant to penicillin, cephalothin, and cephamandole and susceptible to moxalactam and cefoxitin. All species except L. micdadei produced beta-lactamase.

UI MeSH Term Description Entries
D007875 Legionella Gram-negative aerobic rods, isolated from surface water or thermally polluted lakes or streams. Member are pathogenic for man. Legionella pneumophila is the causative agent for LEGIONNAIRES' DISEASE.
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley
November 1981, The American journal of medicine,
A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley
April 1981, Annals of internal medicine,
A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley
January 1983, Scandinavian journal of infectious diseases,
A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley
March 1983, Lancet (London, England),
A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley
March 1983, JAMA,
A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley
May 1981, The Western journal of medicine,
A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley
January 1980, Journal of medicine,
A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley
April 1981, Journal of clinical microbiology,
A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley
November 1984, Chest,
A W Pasculle, and J N Dowling, and R S Weyant, and J M Sniffen, and L G Cordes, and G M Gorman, and J C Feeley
June 1985, Applied and environmental microbiology,
Copied contents to your clipboard!